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Abstract. Reference values derived from developed countries are used in many countries in Africa for interpretation
of laboratory results obtained during routine healthcare and clinical trials. Use of locally derived reference values has
been recommended. The purpose of the study was to establish age- and sex-specific reference values for children in the
middle belt of Ghana. Reference values were determined for 21 biochemical and 18 hematologic parameters by using
Clinical and Laboratory Standards Institute C28-A3 guidelines in a sample of 1,442 healthy children. Hemoglobin,
hematocrit, mean cell volume, erythrocytes, urea, and creatinine were lower when compared with values from northern
countries but alanine aminotransferase, aspartate aminotransferase, and total bilirubin were higher. A panel of locally
relevant age- and sex-specific reference values was established for commonly used biochemical and hematologic tests
in children in the middle part of Ghana. This will help in interpretation of laboratory results for clinical management
of patients, screening, and safety monitoring during clinical trials.
INTRODUCTION
Locally derived biochemical and hematological reference
values are essential for assessing disease and monitoring the
effects of therapy during routine healthcare practice and clin-
ical trials. It has been recommended by the Clinical and Lab-
oratory Standards Institute (CLSI)1 and the International
Federation for Clinical Chemistry2 that each laboratory estab-
lishes reference values appropriate for the population it intends
to serve. However, biochemical and hematologic reference
values used in many countries in Africa were established by
using data from populations in the industrialized countries3–5
because the process of establishing reliable local reference
values is expensive and time-consuming.1 Published literature
has confirmed differences between reference values obtained
for adults from the industrialized countries and those from
countries in Africa.3,6–13 Furthermore, differences also exist
between reference values established in different countries
in Africa.6,8,9,14,15
There is scarcity of comprehensive reference values for chil-
dren in Africa. Values from textbooks, instrument manuals and
reagent inserts that have been derived from Caucasians in
industrialized countries are often used to interpret laboratory
results in settings in Africa.3,16 In some instances, biochemical
and hematologic results for children are interpreted by using
values established with adult populations.17 It is, however,
important to emphasize that children are not small adults and
reference values derived with adult populations may not be
suitable for children. Also, children are constantly changing
and developing and therefore, single reference values may not
be appropriate for children of all ages.17 It therefore necessi-
tates establishing age-specific reference values to aid appropri-
ate interpretation of biochemical and hematologic results of
children. The purpose of this study was to establish a compre-
hensive, age-specific reference values for biochemical and
hematological tests for healthy children in the Kintampo North
Municipality and Kintampo South District, both located in the
middle part of Ghana.
METHODS
Study site. This cross-sectional study was conducted during
September 2009–December 2010 in the Kintampo North
Municipality and Kintampo South District of the Brong
Ahafo Region of Ghana. The studied area is located between
7°43¢N and 8°44¢N and 1°25¢W and 2°1¢W. It lies within the
forest-savannah transitional ecological zone and has an eleva-
tion ranging between 60 and 150 meters above sea level. The
Kintampo Health Research Center maintains a Health and
Demographic Surveillance System (HDSS) that records detailed
demographics of all residents, including pregnancies, births,
deaths, and migrations (in and out) at four-month intervals.18
TheHDSS is made up of a resident population of approximately
140,000 persons. All houses have been digitized to make selec-
tion and tracing of persons to their homes easy.
Reference population. Study communities and children
from birth to 17 years of age were randomly selected from
the HDSS human population by using the Visual FoxPro
software. Community meetings were held to explain the
objectives of the study to the community leaders and other
community members.
The methods used for this study has been described.6 In
brief, persons selected through randomization were invited to
a central location where individual consenting, screening, and
blood collections were conducted. Inclusion into the study was
based on willingness of the child and the parent/caregiver to
participate in the study, demonstrated by the completion and
signing/thumb printing of the consent form and willingness to
provide the samples required; general good health, as deter-
mined by a clinician using medical history and physical exami-
nation; and residence in the study area (as defined by the rules
and guidelines for the Demographic Surveillance System).
Children with evidence of acute or chronic respiratory, cardio-
vascular, gastrointestinal, hepatic, or genitourinary conditions;
history of blood donation/transfusion within three months pre-
ceding the survey; hospitalization within a month preceding the
survey; or any other findings that in the opinion of the examin-
ing clinician may compromise the assessment of the laboratory
parameters of interest in this study were excluded. Adolescent
females assessed to be pregnant (either clinically or by positive
urine test result: human chorionic gonadotrophic hormone
test) or lactating were excluded.
*Address correspondence to David K. Dosoo, Kintampo Health
Research Centre, Kintampo, Ghana. E-mail: david.dosoo@kintampo-
hrc.org
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Blood collection. A maximum of 5 mL of venous blood
samples were collected from the antecubital fossa by using
aseptic methods, and dispensed into K3EDTA, serum separa-
tor tubes with gel, and fluoride-EDTA tubes for hematology,
biochemistry and glucose analysis, respectively. Sample tubes
were obtained from Becton Dickinson (Plymouth, United
Kingdom). Blood samples collected in K3EDTA and fluoride-
EDTA were stored and transported in cold styrofoam boxes
and those collected in serum separator tubes were stored in
styrofoam boxes without cold packs but covered to protect
samples from heat and sunlight.
Hematologic analysis. Hemoglobin, hematocrit, red blood
cell count (RBC), mean cell volume (MCV), mean cell hemo-
globin (MCH), mean cell hemoglobin concentration, red
blood cell distribution width, platelets, platelet distribution
width, total white blood cell count (WBC), lymphocytes,
monocytes, and granulocytes were measured by using vali-
dated ABX Micros 60 Hematology Analyzers (Horiba-ABX,
Montpellier, France). Reagents, calibrators, and controls
were obtained from the instrument manufacturer. Analysis
of samples was performed within 8 hours of blood draw.
Biochemical analysis. Blood samples for biochemical anal-
ysis were allowed to clot for at least 60 minutes, centrifuged,
and serum was collected. Serum was analyzed within 24 hours
after collection. If testing was delayed, serum was stored
frozen at −80°C and subjected to a single freeze–thaw cycle
at the time of analysis. Eighteen tests (alanine aminotransferase
[ALT], aspartate aminotransferase [AST], amylase, creatine
kinase, g-glutamyltransferase [GGT], lactate dehydrogenase
[LDH], total protein, albumin, total and direct bilirubin, choles-
terol, glucose, iron, triglycerides, urea, creatinine, uric acid, and
phosphorus) were measured by using the Vitalab Selectra E
Clinical Chemistry Analyzer (Vital Scientific, Dieren, The
Netherlands). Test tubes were also obtained from Vital Scien-
tific, The Netherlands. Reagents, calibrators, and controls were
obtained from Elitech Diagnostics (Sees, France). Electrolytes
(chloride, potassium, and sodium) were analyzed by using
the Humalyte Electrolyte Analyzer (Human Diagnostics,
Wirsbaden, Germany). Reagents were obtained from the man-
ufacturer of the instrument. The method used for each test is
shown in Table 1.
Quality control. Normal and abnormal controls were run
daily. No analysis was performed if controls were out of
range. In addition to the internal quality assessment, the lab-
oratory participates in external quality assessments for hema-
tology and clinical chemistry with the College of American
Pathologists and the United Kingdom National External
Quality Assessment Scheme. The laboratory complies with
the principles of Good Clinical Laboratory Practice.19,20
Children with abnormal clinical or laboratory test results were
referred for appropriate care and treatment.
Data management and statistical analysis. Data were
recorded on questionnaires, double-entered into a Visual
FoxPro 9.0 database, and verified. Children were grouped by
ages: 0.5–4 years, 5–12 years, and 13–17 years. The last age
group (which represented the pubertal period) was further
grouped by sex because of sex-related differences during this
period.14,21 Data analysis was carried out by using Stata 11
(StataCorp LP, College Station, TX). The 2.5th and 97.5th
percentiles were determined non-parametrically as per the
CLSI C28-A3 guidelines on defining, establishing, and verify-
ing reference intervals in the clinical laboratory.1 To obtain
these intervals with 90% confidence intervals, a minimum of
120 observations were required for each parameter within
each subgroup. Outliers within each subgroup were identified
by using the Dixon method.1 Briefly, the extreme values were
retained in the distribution if D/R < 0.33, where D is the
absolute difference between the most extreme distribution
and the next value and R is the range (maximum–minimum).
Reference values were determined separately for males,
females, and for combined sexes. Differences between sexes
were tested by using the Mann-Whitney test. Values defined
were compared with reference values obtained from the north-
ern industrialized countries and other countries in Africa.
Ethical considerations. Ethics Committees of the Kintampo
Health Research Center, the Noguchi Memorial Institute for
Medical Research, and the National Ghana Health Service
approved this study. Written informed consent was obtained
for each participant who was ³ 8 years of age and from
parents or caregivers before being involved in any activities
in the study. The parents or caregivers of all children who
were < 8 years of age provided consent.
RESULTS
A total of 1,542 children 0.5 years (i.e., 6 months) through
17 years of age were screened for enrollment into this cross-
sectional study. Of these children, 1,442 (93.5%) were eligible
based on the inclusion/exclusion criteria and were enrolled
into the study. Reasons for ineligibility were use of prescribed
drugs within two weeks before study (44), physical signs
of any chronic/acute illness (26), residence in study area
for < 3 months (13), history of any chronic illness (8), hospital-
ization within a month preceding the survey (5), blood transfu-
sion within three months preceding the survey (3), and refusal
for blood draw (1). Data for 15 participants were not included
in the analysis because hemoglobin values were < 6.0 g/dL,
platelet counts were < 50 + 10
9/L, or a homozygous hemoglo-
bin S genotype was present.
The laboratory analytical methods used in the biochemical
tests are shown in Table 1. Median and reference values
Table 1
Laboratory analytical methods used for biochemical tests,
Kintampo, Ghana*
Test Analytical method used
ALT and AST IFCC modified without pyridoxal phosphate
Amylase 2-Chloro-4-nitrophenyl-a-maltotrioside
Creatine kinase IFCC, UV kinetic with imidazole buffer
GGT L-g-Glutamyl-3-carboxy-p-nitroanilide
LDH UV kinetic, pyruvate to lactate
Total protein Biuret
Albumin Bromocresol green with succinate buffer
Total and direct
bilirubin
Malloy-Evelyn modified, end-point
Cholesterol Cholesterol oxidase/peroxidase
Glucose Glucose oxidase/peroxidase
Iron Chromazurol
Triglycerides Lipase/glycerol kinase/glycerol peroxidase
Urea Urease, UV kinetic
Creatinine Jaffe kinetic
Uric acid Uricase/peroxidase
Phosphorus Phosphomolybdate
Electrolytes Ion selective electrode, direct
*ALT = alanine aminotransferase; AST = aspartate aminotransferase; IFCC = International
Federation for Clinical Chemistry; GGT = g-glutamyltransferase; LDH = lactate dehydroge-
nase; UV = ultraviolet.
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(2.5th and 97.5th percentiles) of the biochemical tests for
children 0.5–12 years of age and 13–17 years of age are shown
in Tables 2 and 3, respectively. Median values for AST, direct
bilirubin, LDH, phosphorus, and potassium decreased pro-
gressively with age. Although albumin, cholesterol, and iron
decreased progressively in the children, they later increased in
the adolescents. Creatinine and urea increased progressively
with age throughout the study. Amylase increased with age
Table 2
Biochemical reference values for children 0.5–12 years of age in Kintampo, Ghana*
Parameters Unit
Age groups of children
0.5–4.9 years 5–12 years
No. Median value Reference value No. Median value Reference value
Enzymes
ALT U/L 491 20 7–55 473 20 5–53
AST U/L 489 39 23–72 471 31 19–57
Amylase U/L 466 53 12–136 471 69 33–133
CK U/L 454 108 35–291 474 159 59–515
GGT U/L 453 13 3–34 474 14 7–31
LDH U/L 257 608 360–995 439 509 277–823
Serum proteins
Protein, total g/dL 456 69.7 56.0–87.0 457 73.2 54.0–87.9
Albumin g/dL 471 44.3 35.9–50.0 476 42.6 34.2–49.8
Metabolism
Bilirubin, total mmol/L 501 5.8 1.8–21.0 485 6.7 1.7–18.9
Bilirubin, direct mmol/L 439 1.5 0.4–3.6 392 2.1 0.6–3.9
Cholesterol mmol/L 467 3.1 1.7–5.0 477 2.8 1.7–4.3
Glucose mmol/L 501 4.7 3.2–6.8 473 4.7 3.5–6.2
Iron mmol/L 407 10.0 4.2–20.1 456 9.7 3.88–19.0
Triglycerides mmol/L 460 1.2 0.5–2.7 475 0.9 0.5–1.91
Kidney function
Urea mmol/L 380 1.8 1.0–4.2 473 1.9 1.0–4.5
Creatinine mmol/L 483 33 17–52 471 50 33–74
Uric acid mmol/L 466 179 71–340 464 170 72–274
Chloride mmol/L 380 108 98–115 423 107 99–114
Phosphorus mmol/L 459 1.71 1.26–2.25 477 1.42 1.03–1.84
Potassium mmol/L 388 4.6 3.6–5.8 469 4.4 3.6–5.6
Sodium mmol/L 379 143 131–149 415 144 135–151
*ALT = alanine aminotransferase; AST = aspartate aminotransferase; CK = creatine kinase; GGT = g-glutamyltransferase; LDH = lactate dehydrogenase.
Table 3
Biochemical reference values for adolescents in Kintampo, Ghana*
Parameters Unit
Males Females Persons 13–17 year of age
No. Median value Reference value No. Median value Reference value No. Median value Reference value
Enzymes
ALT† U/L 157 23 10–61 124 20 7–48 281 22 8–55
AST† U/L 157 30 18–67 123 24 11–49 280 28 14–62
Amylase U/L 160 62 31–119 127 60 30–123 287 61 31–120
CK† U/L 153 258 96–572 124 191 91–567 277 218 94–562
GGT U/L 157 16 5–47 125 15 8–30 282 15 6–45
LDH† U/L 149 474 284–751 86 415 212–732 235 450 252–737
Serum proteins
Protein, total g/L 149 71.6 45.2–86.0 123 72.4 46.7–87.3 272 71.8 46.4–86.5
Albumin† g/L 160 42.0 34.3–48.9 126 43.2 37.8–50.5 286 42.7 35.4–49.3
Metabolism
Bilirubin, total mmol/L 160 8.4 3.3–22.0 128 8.0 3.2–21.4 288 8.1 3.3–21.6
Bilirubin, direct† mmol/L 124 2.6 1.2–4.0 101 2.2 0.8–3.9 225 2.4 0.9–4.0
Cholesterol† mmol/L 161 2.8 1.7–3.9 127 3.2 2.0–5.3 288 3.0 1.8–4.6
Glucose mmol/L 161 4.9 3.5–6.8 128 4.9 3.7–6.5 289 4.9 3.6–6.7
Iron mmol/L 155 11.8 4.6–23.3 119 12.0 3.8–23.9 274 11.9 4.6–23.3
Triglycerides mmol/L 157 0.8 0.4–1.8 127 0.9 0.5–1.7 284 0.80 0.40–1.70
Kidney function
Urea† mmol/L 160 2.2 1.0–5.5 127 1.9 1.0–3.6 287 2.1 1.0–4.5
Creatinine† mmol/L 130 62 42–79 116 60 33–78 246 61 39–79
Uric acid† mmol/L 159 211 79–334 127 169 76–285 286 186 78–322
Chloride mmol/L 141 107 95–117 112 107 98–115 253 107 96–116
Phosphorus† mmol/L 161 1.36 0.95–1.79 127 1.24 0.96–1.65 288 1.30 0.96–1.77
Potassium mmol/L 159 4.5 3.6–5.8 126 4.4 3.6–6.1 285 4.4 3.6–5.9
Sodium mmol/L 138 144 132–156 108 145 132–151 246 144 132–152
*ALT = alanine aminotransferase; AST = aspartate aminotransferase; CK = creatine kinase; GGT = g-glutamyltransferase; LDH = lactate dehydrogenase. Adolescents are classified as children
13–17 years of age.
†Parameters with significant sex differences.
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in the children but decreased in the adolescents. Levels of
ALT, GGT, total protein, and total bilirubin remained almost
invariable throughout the study. Levels of CK and uric acid
showed great variation, increasing in the 5–12 year subgroup
and decreasing in adolescents.
Adolescent males had significantly higher levels of ALT
(10–61 U/L versus 7–41 U/L; P < 0.01), AST (18–67 U/L versus
11–49 U/L; P < 0.01), CK (96–572 U/L versus 91–567 U/L; (P <
0.01), LDH (284–751 U/L versus 212–732 U/L; P < 0.01), direct
bilirubin (1.2–4.0 mmol/L versus 0.8–3.9 mmol/L; P = 0.02), urea
(1.0–5.5 mmol/L versus 1.0–3.6 mmol/L; P < 0.01), creatinine
(42–79 mmol/L versus 33–78 mmol/L; P = 0.01), uric acid (79–
334 mmol/L versus 76–285 mmol/L; P < 0.01), and phosphorus
(0.95–1.79 mmol/L versus 0.96–1.65 mmol/L; P < 0.01) than
female counterparts. However, adolescent females had sig-
nificantly higher levels of albumin (34.3–48.9 g/L versus 37.8–
50.5 g/L; P = 0.01) and cholesterol (2.0–5.3 mmol/L versus
1.7–3.9 mmol/L; P < 0.01) than males.
Median and reference values of hematology tests for chil-
dren 0.5–12 years of age and 13–17 years of age are shown in
Tables 4 and 5, respectively. There was a steady increase in
the red blood cell parameters (hemoglobin, hematocrit, RBC,
MCV, and MCH) with age. Conversely, platelets and total
WBC counts showed a decrease with age. In adolescents
(children 13–17 years of age) cohort, significantly higher
values were observed for hemoglobin (10.4–14.8 g/dL versus
9.4–14.2 g/dL; P = 0.01)), hematocrit (31.1–45.1% versus
25.4–45.1%; P = 0.03), RBC (3.79–5.69 + 10
12/L versus 3.53–
5.57 + 10
12/L; P < 0.01), granulocytes (33.6–64.4% versus
30.8–64.0%; P = 0.01), and granulocyte numbers (1.4–5.4 +
109/L versus 1.6–5.2 + 10
9/L; P = 0.04) in males than in
females. Lower values were observed in males than in females
for platelets (108–326 + 10
9/L versus 143–390 + 10
9/L; P =
0.02), PDW (11.9–20.8 versus 12.4–24.1; P = 0.01), and lym-
phocytes (26.5–56.7% versus 25.7–60.2%; P = 0.01). No
sex differences were observed for MCV, MCH, mean cell
Table 4
Hematologic reference values for children 0.5–12 years of age in Kintampo, Ghana*
Parameters Unit
Age groups of children
0.5–4.9 years 5–12 years
No. Median value Reference value No. Median value Reference value
Hemoglobin g/dL 499 10.3 8.0–12.7 484 11.5 9.1–13.5
Hematocrit % 499 31.6 24.4–38.8 485 34.4 27.3–41.5
RBC + 1012/L 499 4.38 3.22–5.55 485 4.36 3.45–5.29
MCV fl 499 73 56–87 483 80 68–89
MCH Pg 498 23.9 16.9–29.7 483 26.5 21.4–30.3
MCHC g/dL 493 32.4 30.0–36.9 481 33.2 30.9–36.0
RDW % 498 16.1 12.5–21.6 484 13.7 11.5–17.9
Platelets + 1012/L 498 301 110–637 479 239 117–417
PDW % 497 16.0 8.8–25.4 484 15.0 12.1–20.5
WBC, total + 109/L 499 9.8 5.1–17.6 485 6.6 4.1–11.9
Lymphocytes % 499 56.8 34.9–75.6 484 45.6 29.6–62.5
Lymphocytes + 109/L 499 5.5 2.3–11.9 485 2.9 1.6–5.8
Monocytes % 499 7.7 4.9–13.6 485 8.6 5.0–13.3
Monocytes + 109/L 499 0.7 0.2–1.0 484 0.5 0.2–1.1
Granulocytes % 499 35.2 18.5–59.7 481 45.1 28.3–62.4
Granulocytes + 109/L 499 3.5 1.5–8.5 484 3.1 1.6–6.2
*RBC = red blood cell; MCV = mean cell volume; MCH = mean cell hemoglobin; MCHC = mean cell hemoglobin concentration; RDW = red blood cell distribution width; PDW = platelet
distribution width; WBC = white blood cell.
Table 5
Hematologic reference values for adolescents in Kintampo, Ghana*
Parameters Unit
Male Female Combined
No. Median value Reference value No. Median value Reference value No. Median value Reference value
Hemoglobin† g/dL 161 12.4 10.4–14.8 128 12.3 9.4–14.2 289 12.2 9.5–14.4
Hematocrit† % 161 37.4 31.1–45.1 128 36.9 25.4–45.1 289 37.2 29.4–44.9
RBC† + 1012/L 161 4.66 3.79–5.69 128 4.50 3.41–5.40 289 4.58 3.53–5.57
MCV Fl 161 82 66–92 127 83 67–94 288 82 67–93
MCH Pg 161 27.2 21.6–31.4 128 27.2 20.9–35.0 289 27.2 21.2–32.0
MCHC g/dL 161 33.1 30.8–35.9 124 32.9 30.1–37.2 285 33.0 30.5–36.6
RDW % 161 13.7 11.5–16.1 127 13.4 11.7–16.0 288 13.5 11.6–16.1
Platelets + 1012/L 159 220 108–326 125 232 143–390 284 226 113–363
PDW† % 161 15.4 11.9–20.8 121 15.7 12.4–24.1 282 15.5 12.4–22.6
WBC, Total + 109/L 160 6.0 3.6–10.3 127 5.7 3.8–9.3 287 5.9 3.7–9.4
Lymphocytes† % 161 41.5 26.5–56.7 128 44.9 25.7–60.2 289 43.0 26.6–58.9
Lymphocytes + 109/L 160 2.4 1.4–4.2 127 2.6 1.4–3.9 287 2.5 1.4–4.0
Monocytes % 161 8.1 4.8–14.0 128 7.9 4.9–14.7 289 8.0 4.9–14.4
Monocytes + 109/L 162 0.4 0.2–1.0 129 0.4 0.2–0.9 289 0.4 0.2–0.9
Granulocytes† % 158 49.2 33.6–64.4 127 47.1 30.8–64.0 285 48.2 31.0–64.0
Granulocytes† + 109/L 159 3.1 1.4–5.4 126 2.7 1.6–5.2 285 2.9 1.6–5.2
*RBC = red blood cell; MCV = mean corpuscular volume; MCH = mean cell hemoglobin; MCHC = mean cell hemoglobin concentration; RDW = red blood cell distribution; PDW = platelet
distribution width; WBC = white blood cell. Adolescents are classified as children 13–17 years of age.
†Parameters with significant sex differences.
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hemoglobin concentration, red blood cell distribution width,
total WBC, lymphocytes (absolute numbers) and monocytes.
DISCUSSION
This achieved its aim of establishing comprehensive bio-
chemical and hematologic reference values that would serve
as standards for the interpretation of laboratory results
for children in routine healthcare practice and screening/
follow-up during clinical trials in the Kintampo area of Ghana,
as well as in populations with similar profiles.
One of the difficulties when establishing reference values
for children is how the population should be subdivided.17
Grouping children into the 0.5–4 years, 5–12 years, and 13–
17 years of age groups (male and female) was performed
based on the subgroups used for similar studies in Uganda15
and Tanzania14 and also based on recommendations to estab-
lish sex-specific reference values during the pubertal stage.21
Determination of the values by using combined sex for chil-
dren < 13 years of age was based on the general absence of
sex differences for the parameters in these age groups.14,15,22
There is a dearth of comprehensive age- and sex-specific
biochemical reference values for children in Africa. Most
published biochemical reference values for children in Africa
usually do not cover the entire subpopulations of children
(i.e., infants, pre-adolescents, and adolescents) and only a
limited number of tests are presented.4,16,23
We have established in this study age- and sex-specific ref-
erence values for a wide range of biochemical tests, including
liver, kidney and cardiac function tests, lipids, iron, and
glucose. For the commonly used biochemical tests during
screening/enrollment and safety monitoring of children in the
Kintampo study area, higher values were obtained for ALT,
AST and total bilirubin compared with values from children
in the developed countries, and creatinine and urea levels
were lower (Table 6). Although there are differences in the
values of some of these parameters when compared with
other studies in Africa,4,14,16,23 similar patterns were observed
when compared with Caucasian values.17,22 A possible cause
of higher liver enzyme levels (ALT and AST) is subclinical
viral infections or the use of herbal preparations.3 Although
screening for hepatitis was not performed, prevalence of these
viruses among blood donors in Ghana is 7–15% for hepatitis
B virus26,27 and 7–11% for hepatitis C virus.26 Regarding
the use of herbal preparations, it has been estimated that the
Table 6
Comparison of commonly used biochemical reference values for
adolescents in Kintampo, Ghana, with those for Kenya and a
developed country*
Parameters Kintampo Kenya23 Developed country22
ALT, U/L
M 10–61 5–42 10–33
F 7–48 4–65 8–24
AST, U/L
M 18–67 17–59 18–40
F 11–49 12–43 17–33
Bilirubin, total, mmol/L
M 3.3–22.0 5.7–62.6 1.7–14.4
F 3.2–21.4 3.7–38.5 1.7-1-4.4
Bilirubin, direct, mmol/L
M 1.2–4.0 NA 1.9–7.1
F 0.9–4.0 NA 1.7–6.7
Creatinine, mmol/L
M 42–79 50–104 58–92
F 33–78 48–88 52–76
Urea, mmol/L
M 1.0–5.5 NA 2.6–7.5
F 1.0–3.6 NA 2.6–6.8
*ALT = alanine aminotransferase; AST = aspartate aminotransferase; NA = not available.
Table 7
Comparison of commonly used hematologic reference values for children in Kintampo, Ghana, with those for Uganda, Tanzania, and
developed countries*
Parameters Kintampo Uganda15 Tanzania14 WHO (lower limits)24,25†
Hemoglobin, g/dL
0.5–4 years old 8.0–12.6 8.8–12.5 8.1–13.9 11.0
5–12 years old 9.1–13.5 10.0–13.7 10.3–14.7 11.5
13–17 years old (M) 10.4–14.8 11.2–15.9 10.8–17.0 13.0
13–17 years old (F) 9.4–14.2 9.9–14.5 10.0–14.9 12.0
Hematocrit, %
0.5–4 years old 24.4–38.8 25.9–36.3 26.5–40.8 33.0
5–12 years old 27.3–41.5 29.2–39.4 31.9–43.5 34.0
13–17 years old (M) 31.1–45.1 32.3–45.5 33.0–48.1 39.0
13–17 years old (F) 25.4–45.1 28.1–42.2 30.8–44.7 36.0
MCV
0.5–4 years old 56–87 60.7–82.8 54.7–91.6 73
5–12 years old 68–89 63.3–83.9 66.0–90.0 76
13–17 years old (M) 66–92 65.0–89.5 63.2–91.0 79
13–17 years old (F) 67–94 67.4–89.9 62.2–94.5 78
MCH
0.5–4 years old 16.7–31.3 NA NA 25
5–12 years old 21.4–30.3 NA NA 26
13–17 years old (M) 21.6–31.4 NA NA 27
13–17 years old(F) 21.2–32.0 NA NA 26
RBC, + 1012/L
0.5–4 years old 3.22–5.55 3.50–5.20 NA 3.7
5–12 years old 3.45–5.24 3.80–5.40 NA 3.8
13–17 years old (M) 3.79–5.69 4.10–5.80 NA 4.2
13–17 years old (F) 3.53–5.57 3.50–5.40 NA 3.9
*WHO =World Health Organization; MCV = mean cell volume; MCH = mean cell hemoglobin; NA = not available; RBC = red blood cell.
†Age ranges for MCV, MCH, and RBC = 2–4.9 years, 8–11.9 years, and 15–17 years (M and F).
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first-line treatment of 60% of children with fever resulting
from malaria in Ghana, Mali, Nigeria and Zambia has been
the use of herbal medicine at home.28 Low protein intake
could account for the decreased levels of urea observed in this
study.29 Medical decision limits are more appropriate for some
parameters (such as glucose, cholesterol, and triglyceride) for
monitoring and assessment of disease than population-based
reference values.1 However, reference values defined for the
healthy population of children in this study is of epidemio-
logic interest.22 Higher triglyceride values for children less
than five years of age could be caused by samples being col-
lected from persons in a non-fasting state.
Red blood cell parameters derived in this study are on the
lower side when compared with cut-off values used by the
World Health Organization (Table 7).24,25 This finding is syn-
onymous with those of many studies that established hemato-
logic reference values for children in Africa.4,14,16,23 Factors
contributing to the lower values include poor nutritional
status (e.g., iron deficiency), chronic blood loss resulting from
parasitic infections (e.g. hookworm and schistosomes) and
hemoglobinopathies.8,14 The finding of significant sex differ-
ences in the red blood cell parameters (hemoglobin, hemato-
crit, and RBC count) among adolescents is consistent with
previously evidence that adolescent males have higher values
than females for these parameters.14,23 The reasons for these
differences have been attributed to factors such as the influ-
ence of the androgen hormone on erythropoiesis and to men-
strual blood loss in females.8–10,15,30
The upper limits of the platelet values for infants in this
study were higher than those for infants in the developed
countries. Similar findings have been observed in other coun-
tries in Africa, such as Gabon,16 Mozambique,4 Uganda15 and
Tanzania.14 No clear reasons could be attributed to this find-
ing that is in contrast with lower platelet counts reported for
African adults compared with those for Caucasians.6,30–33
However, the steady decrease in maximum platelet counts
with age from birth up to adolescence is a finding that has
been established in Caucasians and Africans. Malaria-related
thrombocytopenia could be one of the contributing factors to
low platelet counts in our study,13,34 in addition to dietary,
environmental, and genetic factors’31,32,35 White blood cells
counts for children £ 4 years of age in this study were compa-
rable to those of children of the same ages in developed
countries. However, lower WBC values were observed in chil-
dren 5–17 years of age. Similar findings of lower WBC values
in children within this age range have been reported in other
studies in Africa.14,15 This finding continues into adult-
hood.6,8,35 Lower WBC counts in Africans could be caused
by dietary, genetic, and environmental factors.
This study is important because it emphasizes the need for
the use of locally derived reference values to be used to guide
in interpreting biochemical and hematologic results in clinical
practice and clinical trials and determining eligibility and
reporting of adverse events during clinical trials. The use of
inappropriate reference values obtained from industrialized
populations would result in the exclusion of otherwise healthy
participants (leading to unnecessary prolongation of clinical
trials), over-reporting of adverse events during clinical
trials, and inappropriate treatment of patients in routine
healthcare practice.
Before enrollment and blood sample collection, the chil-
dren who participated in this study were examined by clini-
cians to determine their health status. Only those who were
found to be healthy were enrolled. However, the selection of
a normal group for the determination of laboratory reference
values is complex and not all medical conditions could be
screened at the time of this study. Therefore, it is possible that
a small proportion of the children who had minor illnesses
might not have been detected. However, as much as practical,
children with conditions such as signs/history of acute or
chronic diseases, hospitalization within a month before the
study, or sickle cell disease were not included in the analysis.
Data for participants with significant abnormality were not
used in the determination of the reference intervals.
The reference values developed for children in the
Kintampo study area will be of immense benefit to most clin-
ical trials requiring screening and monitoring of hematologic
and biochemical parameters and for patient care in general.
Compared with values for those in the developed countries,
the reference values for hemoglobin, hematocrit, RBC
counts, and urea are lower in the Kintampo study area. These
values may be used in laboratories in other parts of Ghana
and Africa after some form of validation, as recommended
by the CLSI.
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